
Bioethicists call for oversight of poorly regulated, consumer-grade neurotechnology products (Medical News):
“The marketing of direct-to-consumer “neurotechnologies” can be enticing: apps that diagnose a mental state, and brain devices that improve cognition or “read” one’s emotional state. However, many of these increasingly popular products aren’t fully supported by science and have little to no regulatory oversight, which poses [Read more…] about Bioethicists call for stronger oversight of direct-to-consumer neurotechnologies